BiotechTube
Data
Discover
News
Company
Search...
โK
Sign in
BiotechTube
Home
/
Optieum Biotechnologies
/
Toshiki Ochi
TO
Toshiki Ochi
Scientific Founder, Co-Founder & Advisor
Optieum Biotechnologies
Therapeutic Areas
Oncology
Immunology
Optieum Biotechnologies Pipeline
Drug
Indication
Phase
PROGRAM-1
solid tumor, cancer associated fibroblast
Pre-Clinical
PROGRAM-2
hematological malignancies, autoimmune disorders
Pre-Clinical
PROGRAM-3
Undisclosed
Discovery
Leadership Team at Optieum Biotechnologies
SN
Shun Nishioka
President & CEO
DM
Dan MacLeod
Chief Scientific Officer
SC
Stewart Craig
Chief Technology Officer
KN
Kenji Nakamaru
Head of R&D, Vice President
View full Optieum Biotechnologies profile